Low expression of fragile histidine triad gene correlates with high proliferation in head and neck squamous cell carcinoma

被引:19
|
作者
Mineta, H
Miura, K
Takebayashi, S
Misawa, K
Ueda, Y
Suzuki, I
Ito, M
Wennerberg, J
机构
[1] Hamamatsu Univ Sch Med, Dept Otolaryngol, Hamamatsu, Shizuoka 4313192, Japan
[2] Univ Lund Hosp, Dept Otorhinolaryngol Head & Neck Surg, S-22185 Lund, Sweden
[3] Hamamatsu Univ Hosp, Div Pathol, Hamamatsu, Shizuoka 4313192, Japan
关键词
fragile histidine triad (FHIT) gene; head and neck cancer; immunohistochemistry; Ki-67; expression;
D O I
10.1016/S1368-8375(02)00022-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Frequent loss of heterozygosity in head and neck squamous cell carcinoma (HNSCC) has been found in several chromosomal regions such as 3p, 9p, 11q, 13q and 17p. Fragile histidine triad (FHIT) gene is located at 3p14.2 encompassing a common fragile site, and is identified as a tumor suppressor gene. We examined 57 patients with HNSCC using immunohistochemistry, western blot, and reverse transcriptase polymerase chain reaction. The association between FHIT expression and clinicopathologic characteristics including p53 and Ki-67 expressions was analyzed. Immunohistochemical analysis revealed 30 patients (53%) of low FHIT expression and 27 patients (47%) of high FHIT expression. Low FHIT expression significantly correlated with high Ki-67 expression, indicating that tumor cells with low FHIT expression can proliferate aggressively. No correlation was found between FHIT expression and clinical characteristics including age, gender, tumor size, lymph node status, stage grouping, histologic grade, p53 expression, and prognosis. FHIT alteration may play an important role in cancer development of HNSCC, however it did not contribute to the prognosis. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:56 / 63
页数:8
相关论文
共 50 条
  • [1] Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions
    Kujan, Omar
    Oliver, Richard
    Roz, Luca
    Sozzi, Gabriella
    Ribeiro, Noel
    Woodwards, Robert
    Thakker, Nalin
    Sloan, Philip
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (22) : 6723 - 6729
  • [2] Expression of the Fragile Histidine Triad Gene in Laryngeal Carcinoma
    Tutar, Ediz
    Karatas, Erkan
    Baglam, Tekin
    [J]. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2010, 20 (04): : 229 - 234
  • [3] High SQLE Expression and Gene Amplification Correlates with Poor Prognosis in Head and Neck Squamous Cell Carcinoma
    Liu, Yang
    Fang, Lijun
    Liu, Weixian
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4709 - 4723
  • [5] Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis
    Nan, Ke-Jun
    Ruan, Zhi-Ping
    Jing, Zhao
    Qin, Hai-Xia
    Wang, Hong-Yan
    Guo, Hui
    Xu, Rui
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (02) : 228 - 231
  • [6] Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma
    Guerin, LA
    Hoffman, HT
    Zimmerman, MB
    Robinson, RA
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2006, 130 (02) : 158 - 164
  • [7] Mutation and abnormal expression of the fragile histidine triad gene in nasopharyngeal carcinoma
    Deng, YF
    Tian, F
    Lu, YD
    Chen, ZC
    Xie, DH
    Yang, XM
    Shao, XY
    [J]. LARYNGOSCOPE, 2001, 111 (09): : 1589 - 1592
  • [8] Gene expression profiling in head and neck squamous cell carcinoma
    Braakhuis, Boudewijn J. M.
    Brakenhoff, Ruud H.
    Leemans, C. Rene
    [J]. CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2010, 18 (02): : 67 - 71
  • [9] Expression of abnormal transcripts of the FHIT (fragile histidine triad) gene in ovarian carcinoma
    Mandai, M
    Konishi, I
    Kuroda, H
    Nanbu, K
    Matsushita, K
    Yura, Y
    Hamid, AA
    Mori, T
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 (05) : 745 - 749
  • [10] Loss of fragile histidine triad gene expression is associated with progression of esophageal squamous cell carcinoma, but not with the patient's prognosis and smoking history
    Shimada, Y
    Sato, F
    Watanabe, G
    Yamasaki, S
    Kato, M
    Maeda, M
    Imamura, M
    [J]. CANCER, 2000, 89 (01) : 5 - 11